AlexisAnneThompsonMDMPH

PubMed

• Real-world evidence: Long-term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years.
  Janet L Kwiatkowski, Alexis A Thompson, Fernando Tricta, Noemi Toiber Temin, Anna Rozova, Caroline Fradette, Sherif M Badawy> ;American Journal of Hematology. 2024 Mar 1
• World Coalition on SCD launches, sparking global focus on SCD diagnosis and care.
  Andrew Zapfel, Alexis Thompson, Kenneth Bridges, Juliana Richardson, Lwimba Kasongo, Christophe Przybylski, Charles Kiyaga, Prebo Barango, Isaac Odame> ;Blood Advances. 2023 Nov 28
• Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, ...
  Robert F Sidonio Jr, Alexis A Thompson, Flora Peyvandi, Oleksandra Stasyshyn, Seoh Leng Yeoh, Darintr Sosothikul, Ali Bulent Antmen, Caterina Maggiore, Werner Engl, Br...> ;Expert Review of Hematology. 2023 Sep 7
• 13 citations
  Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
  Frédéric B Piel, David C Rees, Michael R DeBaun, Obiageli Nnodu, Brigitte Ranque, Alexis A Thompson, Russell E Ware, Miguel R Abboud, Allistair Abraham, Emmanuela E Am...> ;The Lancet. Haematology. 2023 Aug 1
• 2 citations
  Psychologists as leaders in equitable science: Applications of antiracism and community participatory strategies in a pediatric behavioral medicine clinical trial.
  Desireé N Williford, Emily A McTate, Anna M Hood, Steven K Reader, Aimee K Hildenbrand, Kim Smith-Whitley, Susan E Creary, Alexis A Thompson, Rogelle Hackworth, Jean L...> ;The American Psychologist. 2023 Apr 3
• 4 citations
  Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease.
  Mary Eapen, Ruta Brazauskas, David A Williams, Mark C Walters, Andrew St Martin, Benjamin L Jacobs, Joseph H Antin, Kira Bona, Sonali Chaudhury, Victoria H Coleman-Cow...> ;Journal of Clinical Oncology. 2023 Apr 20
• 13 citations
  Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.
  Julie Kanter, Alexis A Thompson, Francis J Pierciey Jr, Matthew Hsieh, Naoya Uchida, Philippe Leboulch, Manfred Schmidt, Melissa Bonner, Ruiting Guo, Alex Miller, Jean...> ;American Journal of Hematology. 2023 Jan 1
• 8 citations
  The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology.
  Nancy S Green, Andrew Zapfel, Obiageli E Nnodu, Patience Franklin, Venée N Tubman, Lulu Chirande, Charles Kiyaga, Catherine Chunda-Liyoka, Bernard Awuonda, Kwaku Ohene...> ;Blood Advances. 2022 Dec 27
• 16 citations
  Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled tr...
  Ali T Taher, Maria Domenica Cappellini, Antonis Kattamis, Ersi Voskaridou, Silverio Perrotta, Antonio G Piga, Aldo Filosa, John B Porter, Thomas D Coates, Gian Luca Fo...> ;The Lancet. Haematology. 2022 Oct 1
• Sickle Cell Disease and Gene Therapy - Patient and Physician Perspectives.
  Michael DeBaun, Matthew Heeney, Terry Jackson, Dan Longo, Melesa Love, Trinity Love, Phillip Okwo, Alexis Thompson, Cassandra Trimnell, Teonna Woolford> ;The New England Journal of Medicine. 2022 Sep 29
• 5 citations
  Metformin for treatment of cytopenias in children and young adults with Fanconi anemia.
  Jessica A Pollard, Elissa Furutani, Shanshan Liu, Erica Esrick, Laurie E Cohen, Jacob Bledsoe, Chih-Wei Liu, Kun Lu, Maria Jose Ramirez de Haro, Jordi Surrallés, Maggi...> ;Blood Advances. 2022 Jun 28
• 2 citations
  Clinical phenotypes of three children with sickle cell disease caused by HbS/Sicilian (δβ)-thalassemia deletion.
  Banu Aygun, Adriana Bello, Alexis A Thompson, Lance Davis, Yanan Sun, Hong-Yuan Luo, Shuaiying Cui, David H K Chui> ;American Journal of Hematology. 2022 Apr 1
• 92 citations
  Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
  Julie Kanter, Mark C Walters, Lakshmanan Krishnamurti, Markus Y Mapara, Janet L Kwiatkowski, Stacey Rifkin-Zenenberg, Banu Aygun, Kimberly A Kasow, Francis J Pierciey ...> ;The New England Journal of Medicine. 2022 Feb 17
• 4 citations
  An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
  John Chapin, Alan R. Cohen, Ellis J. Neufeld, Elliott Vichinsky, Patricia J. Giardina, Jeanne Boudreaux, Binh C. Le, Kristy Kenney, Sean Trimble, Alexis A. Thompson> ;British Journal of Haematology. 2021 Nov 14
• 4 citations
  Consensus statement for the perinatal management of patients with alpha thalassemia major.
  Tippi C. MacKenzie, Ali Amid, Michael Angastiniotis, Craig Butler, Sandra Gilbert, Juan M. Gonzalez, Roberta L. Keller, Sandhya Kharbanda, Melanie Kirby-Allen, Barbara...> ;Blood Advances. 2021 Nov 8
• 8 citations
  ASH Research Collaborative: A Real-World Data Infrastructure to Support Real-World Evidence Development and Learning Healthcare Systems in Hematology.
  William A. Wood, Peter W. Marks, Robert M. Plovnick, Kathleen Hewitt, Donna Neuberg, Sam Walters, Brendan K. Dolan, Emily Tucker, Charles S. Abrams, Alexis A. Thompson...> ;Blood Advances. 2021 Oct 21
• 3 citations
  Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalas...
  Sherif M. Badawy, Amanda B. Payne, Mary M. Hulihan, Thomas D. Coates, Suvankar Majumdar, Dominic Smith, Alexis A. Thompson> ;British Journal of Haematology. 2021 Aug 24
• 6 citations
  Time to rethink haemoglobin threshold guidelines in sickle cell disease.
  Samir K. Ballas, Frans A. Kuypers, Victor R. Gordeuk, Jane S. Hankins, Alexis A. Thompson, Elliott Vichinsky> ;British Journal of Haematology. 2021 Jun 15
• 8 citations
  Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial.
  Anna M Hood, Heather Strong, Cara Nwankwo, Yolanda Johnson, James Peugh, Constance A. Mara, Lisa M Shook, William B. Brinkman, Francis J. Real, Melissa Klein, Rogelle ...> ;JMIR Research Protocols. 2021 May 21
• 19 citations
  Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
  James F. Casella, Bruce A. Barton, Julie Kanter, L. Vandy Black, Suvankar Majumdar, Adlette Inati, Yasser Wali, Richard A. Drachtman, Miguel R. Abboud, Yurdanur Kilinç...> ;JAMA. 2021 Apr 20
• 15 citations
  The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
  Hanny Al-Samkari, Kathryn Addonizio, Bertil Glader, D. Holmes Morton, Satheesh Chonat, Alexis A. Thompson, Kevin H.M. Kuo, Yaddanapudi Ravindranath, Heng Wang, Jennife...> ;British Journal of Haematology. 2021 Mar 1
• 31 citations
  A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy.
  Sherif M. Badawy, Robert I. Liem, Sonali Chaudhury, Alexis A. Thompson> ;Blood Advances. 2021 Jan 26
• 7 citations
  Summit on Exercise Collapse Associated with Sickle Cell Trait: Finding the "Way Ahead".
  Francis G. O'Connor, M. Alaric Franzos, Nathaniel S. Nye, D. Alan Nelson, Donald Shell, Jameson D. Voss, Scott A. Anderson, Nailah J. Coleman, Alexis A. Thompson, Kimb...> ;Current Sports Medicine Reports. 2021 Jan 1
• 9 citations
  Characterization of the severe phenotype of pyruvate kinase deficiency.
  Hanny Al-Samkari, Eduard J. van Beers, D. Holmes Morton, Wilma Barcellini, Stefan W. Eber, Bertil Glader, Hassan M. Yaish, Satheesh Chonat, Kevin H.M. Kuo, Nina Kollma...> ;American Journal of Hematology. 2020 Jul 3
• 7 citations
  Comorbid Medical Conditions in Young Athletes: Considerations for Preparticipation Guidance During the COVID-19 Pandemic.
  Kimberly G. Harmon, Paul S. Pottinger, Aaron L. Baggish, Jonathan A. Drezner, Andrew M. Luks, Alexis A. Thompson, Sankar Swaminathan> ;Sports Health. 2020 Jun 24
• Join now to see all

Abstracts/Posters

• Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease
  Alexis A Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Relationships between Target Gene Transduction, Engraftment of HSCs and RBC Physiology in Sickle Cell Disease Gene Therapy
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
  Alexis A Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Probably Pathogenic KMT2D Variants Presenting with Cytopenias and Primary Immune Deficiency
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Resolution of Sickle Cell Disease Manifestations in Patients Treated with Lentiglobin Gene Therapy: Updated Results from the Phase 1/2 Hgb-206 Group C Study
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Exploring the Drivers of Potential Clinical Benefit in Initial Patients Treated in the Hgb-206 Study of Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) Study
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) Study
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Northstar-3: Interim Results from a Phase 3 Study Evaluating Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Either a _0 or IVS-I-110...
  Alexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Non-_0/_0 Genotypes 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Friday Scientific Workshop on Novel Curative Options: Gene-Editing and Gene Therapy for Hemoglobinopathies with a Focus on Sickle Cell Disease 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal 
  60th American Society of Hematology Annual Meeting - 12/4/2018
• Business Meeting 
  60th American Society of Hematology Annual Meeting - 12/4/2018
• Completing the Genome Editing Arc in Hematology 
  60th American Society of Hematology Annual Meeting - 12/4/2018
• ASH Research Collaborative SCD Clinical Trials Network Q&A 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Blood Stem Cells: A Simple Concept, but a Complex Reality 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Bone Marrow Failure: Fanconi Anemia and Aplastic Anemia 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Announcement of Awards: Wallace H. Coulter Award for Lifetime Achievement in Hematology, ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outsta... 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Constitutional Syndromes With Malignant Potential 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Plenary Scientific Session 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia Following Completion of the Northstar Hgb-204 Study 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcomes for Initial Patient Cohorts with up to 33 Months of Follow-up in the Hgb-206 Phase 1 Trial 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all